Some studies have shown that when the NLRP3 inflammasome is activated, it releases downstream pro-inflammatory mediators such as IL-1β and IL-18, which become one of the key factors triggering neuroinflammation after cerebral ischemia–reperfusion (164, 165). This evidence concerns the gene IL1B and brain ischemia.